Carillon Tower Advisers’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$53.8M Buy
310,642
+232,748
+299% +$40.3M 0.33% 100
2020
Q3
$8.67M Buy
+77,894
New +$8.67M 0.12% 272
2020
Q2
Sell
-572,680
Closed -$36.9M 474
2020
Q1
$36.9M Hold
572,680
0.36% 94
2019
Q4
$48.3M Hold
572,680
0.32% 102
2019
Q3
$42.8M Buy
+572,680
New +$42.8M 0.3% 118